Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.22 - $0.47 $23 - $50
-107 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$0.41 - $0.91 $43 - $97
107 New
107 $0
Q3 2021

Nov 15, 2021

SELL
$0.8 - $1.12 $5,596 - $7,835
-6,996 Closed
0 $0
Q2 2021

Sep 13, 2021

BUY
$0.97 - $1.32 $6,786 - $9,234
6,996 New
6,996 $8,000

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $468M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.